[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Cogent Biosciences, Inc. Common Stock (COGT)

Cogent Biosciences' bezuclastinib shows promising results in Systemic Mastocytosis trials, leading to analyst upgrades and a surge towards a 52-week high, despite market volatility and short interest.

About Cogent Biosciences, Inc. Common Stock

Cogent Biosciences, Inc. is a biotechnology company focused on developing therapies for cancer and inflammatory diseases.
Cogent Biosciences, Inc. Common Stock uses the ticker $COGT for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

• Cogent Biosciences, Inc. Common Stock (COGT) trading volume is up XXXXXX% from the previous X months.
• Cogent Biosciences, Inc. Common Stock (COGT) social dominance is up XXXXXX% from the previous week.
• Cogent Biosciences, Inc. Common Stock (COGT) Galaxy Score™ is up XXXXX% from the previous week.
• Cogent Biosciences, Inc. Common Stock (COGT) sentiment is up XX% from the previous week.
• Cogent Biosciences, Inc. Common Stock Price hit a 52-Week high of $XXXXX for the hour
• Cogent Biosciences, Inc. Common Stock Price hit an all time of $XXXXX for the hour

Price: $XX

Price 24-Hour Time-Series Raw Data
The stock price has surged to a 52-week high, driven by positive clinical trial data and FDA designations, as indicated by recent social media posts highlighting its potential and analyst upgrades. However, ongoing market volatility and significant short interest are creating some headwinds.

24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXXX%

1-Year High: $XXXXX on 2025-11-26
1-Year Low: $X on 2025-04-10

AltRank: XXX

AltRank 24-Hour Time-Series Raw Data
Cogent Biosciences, Inc. Common Stock (COGT) is currently AltRank #554 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XXX
1-Year High: XXX on 2025-12-05
1-Year Low: XXX on 2025-11-30

Galaxy Score: XXXXX

Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +10
1-Year High: XX on 2025-12-08
1-Year Low: XX on 2025-11-20

Engagements: XXXXX (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX +198%
X Months: XXXXXXXXX +198%
X Year: XXXXXXXXX +243%
1-Year High: XXXXXXX on 2025-07-07
1-Year Low: XXX on 2024-12-31

Engagements by network (24h): Reddit: X X: XXXXX YouTube: XX

Mentions: XXX (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
X Week: XXX -XXXX%
X Month: XXXXX +118%
X Months: XXXXX +2,108%
X Year: XXXXX +1,174%
1-Year High: XXXXX on 2025-07-08
1-Year Low: X on 2025-01-27

Mentions by network (24h): Reddit: X X: XXX YouTube: X

Creators: XX (24h)

Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Cogent Biosciences, Inc. Common Stock (COGT) in the last XX hours which is down XXXX% from XX in the previous XX hours Daily Average: XX
X Week: XXX -X%
X Month: XXX +91%
X Months: XXXXX +3,515%
X Year: XXXXX +1,970%
1-Year High: XXXXX on 2025-07-08
1-Year Low: X on 2025-01-27

The most influential creators that mention Cogent Biosciences, Inc. Common Stock in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	X	XXXXXX	X	XXXXX
@seedy19tron	X	XXXXX	X	XXX
@monaco_biotech	X	XXXXX	X	XXX
@aipatternlab	X	XXXXX	X	XXX
@doepke_michel	X	XXXXX	X	XX
@OzmosiHealth	X	XXXXX	X	XX
@threadanddoc	X	XXX	X	XX
@PrimeTrading_	X	XXXXXX	X	XX
@bryan_plat47867	X	XXX	X	XX
@Biotech2k1	XX	XXXXXX	X	XX

View More

Sentiment: XX%

Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +21%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-12
1-Year Low: XX% on 2025-04-20

Most Supportive Themes:

• FDA Breakthrough Therapy Designation: (30%) Cogent Biosciences received FDA Breakthrough Therapy Designation for bezuclastinib in Non-Advanced Systemic Mastocytosis.
• Positive Clinical Trial Data: (25%) Upcoming trial readouts (PEAK and APEX) for bezuclastinib are anticipated in Q4 2025, with topline Phase X data expected in November 2025.
• Analyst Ratings and Price Targets: (20%) Raymond James reiterated a Strong Buy rating with a $XX price target, and Guggenheim raised their price target to $XX from $17, reiterating a Buy rating.

Most Critical Themes:

• Market Volatility and Mixed Signals: (40%) Despite positive developments, the overall market is experiencing volatility, creating mixed signals for COGT.
• Short Interest: (35%) The stock has a notable short ratio of XXXX and a short float of 15.11%, indicating significant short pressure.

Social Dominance: XXXXX%

Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.054%
X Month: XXXXX% -XXXXX%
X Months: XXXXX% +0.017%
X Year: XXXXX% +0.0088%
1-Year High: XXXXX% on 2025-07-08
1-Year Low: XXXXXX% on 2025-09-22

Market Dominance: XXXXXXX%

Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-11-26
1-Year Low: XXXXXXX% on 2025-12-11

Market Cap: $XXXXXXXXXXXXX

Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$4.10%
X Month: $XXXXXXXXXXXXX +$20%
1-Year High: $XXXXXXXXXXXXX on 2025-11-26
1-Year Low: $XXXXXXXXXXXXX on 2025-11-04

Top Cogent Biosciences, Inc. Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"52 Week Gainers - US Stocks by Yahoo Finance: $QMMM QMMM $RGC Regencell Bioscience $TAWNF Thai Airways Public $ABVX ABIVAX Socit Anonyme $CDTX Cidara Therapeutics $DSVSF Discovery Silver $TMC TMC the metals company $ONDS Ondas $CELC Celcuity $QBTS D-Wave Quantum $TERN Terns Pharmaceuticals $SNDK Sandisk $OKLO Oklo $BMNR Bitmine Immersion $COGT Cogent Biosciences #StockInFocus"
X Link @aipatternlab 2025-12-11T18:00Z 4462 followers, XXX engagements

"🐔🌈🍒🕑🏡 I discovered the blogger (@safwan22025) on X. After following his analysis for several days I found it highly aligned with market trends.#stock $INTC #XYZ 🚹 $COGT #Take Profit 👆 $HSPO #CoreWeave 🚤 $CHDN #Revenue 🎉 $CG"
X Link @LashawnaMe18618 2025-12-11T01:26Z XX followers, XX engagements

"🚶🌵♍ I discovered the blogger (@safwan22025) on X. After following his analysis for several days I found it highly aligned with market trends.#stock $INTC #Gold 🏛 $COGT #Stock Valuation 🦑 $CRWS #BGE 💻 $CTKB #M&A $CGEN"
X Link @CamilleNav20755 2025-12-10T23:45Z XX followers, XX engagements

"$abvx not getting bought out now. Furus killed it. $jnj buying $ptgx. Long $tern $gpcr $cogt and sleep"
X Link @RudyResearch 2025-12-10T22:24Z XXX followers, 3921 engagements